Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy. A double-blind, placebo-controlled, randomized trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.